Tag Archives: shpg

Shire Moves Higher On NPS Potential; Q4 Earnings Miss

Shares of Shire (SHPG) moved higher early Thursday as the Irish drugmaker’s better-than-expected quarterly revenue and upbeat 2015 outlook offset an earnings miss. Reporting before the open, Shire logged fourth-quarter earnings of $2.63 per American depositary share, up 19% from the year-earlier period but a nickel below consensus estimates of analysts polled by Thomson Reuters. Revenue climbed 19% to $1.58 billion, topping views. It was Shire’s

Shire Agrees To Acquire NPS Pharmaceuticals

Anglo-Irish drugmaker Shire (SHPG) announced on Monday that it had agreed to acquire NPS Pharmaceuticals for $5.2 billion in an all-cash deal. Dublin-based Shire said on Sunday that it will pay $46 a share for NPS Pharmaceuticals (NPSP), which is based in New Jersey and specializes in drugs for gastrointestinal disorders. That represents a 51% premium to NPS Pharmaceuticals share price of 30.47 on Dec. 16, before rumors of the deal emerged. The

Shire CEO Looks Ahead To Independent Future

Flemming Ornskov has been at Shire for only 18 months, but his term has been quite an adventure already. In January, he closed the Anglo-Irish drugmaker’s biggest acquisition, buying U.S. biotech ViroPharma for $4.2 billion. That brought Shire (SHPG) deeper into the growing field of rare-disease drugs, helping it diversify from its core business in attention-deficit treatments. It has also made a number of smaller buyouts. This year, Shire’s